New study shows wearable trackers provide clinical use for heart disease patients
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
Read More
Tag: wearable trackers
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
